tiprankstipranks
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily

Akero Therapeutics (AKRO) Ownership - Who Owns Akero Therapeutics?

485 Followers

Akero Therapeutics (AKRO) Ownership Overview

3.53%24.21%44.09%13.29%14.88%
44.09% Other Institutional Investors
13.29% ETFs
14.88% Public Companies and
Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 81.59% of the company’s stock is owned by Institutional Investors, 3.53% is owned by Insiders, and 14.88% is owned by Public Companies and Individual Investors.
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 68.30% of the company’s stock is owned by Institutional Investors, 3.53% is owned by Insiders, and 13.29% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 12, 2024
xxxxxxxxxxxxx
$86735
Dec 12, 2024
Andrew Cheng
President & Ceo,director
xxxxxxxxxxxxx
$241855
Dec 12, 2024
xxxxxxxxxxxxx
$77067
Dec 12, 2024
xxxxxxxxxxxxx
$86520

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$384331
Sep 30, 2024
xxxxxxxxxxxxx
$8390906
Sep 30, 2024
xxxxxxxxxxxxx
$49197784

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,493,576Institution5.01%102,501,520
3,238,756Institution4.64%95,025,101
2,901,480Institution4.16%85,129,423
2,508,425Institution3.59%73,597,190
2,211,553Institution3.17%64,886,965
1,814,384Institution2.60%53,234,027
1,714,806Institution2.46%50,312,408
1,097,082Institution1.57%32,188,386
1,059,586Institution1.52%31,088,253
802,168Insider1.15%23,535,609

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,901,480Institution4.16%85,129,423
2,508,425Institution3.59%73,597,190
2,211,553Institution3.17%64,886,965
1,814,384Institution2.60%53,234,027
783,745Institution1.12%22,995,078
732,719Institution1.05%21,497,975
608,731Institution0.87%17,860,168
542,464Institution0.78%15,915,894
436,978Institution0.63%12,820,935
355,056Institution0.51%10,417,343

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,926,204Institution2.76%59,384,869
1,945,199Institution2.79%57,072,139
955,892Institution1.37%29,470,150
921,938Institution1.32%26,183,039
557,274Institution0.80%16,350,419
395,624Institution0.57%11,607,608
309,075Institution0.44%9,528,782
307,569Institution0.44%8,734,960
228,454Institution0.33%6,702,840
160,953Institution0.23%4,962,181

FAQ

Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately 44.09% of the company's stock is held by institutional investors, 3.53% is held by insiders, and 14.88% is held by retail investors.
    What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 44.09% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
      What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.88% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
        Who owns the most shares of Akero Therapeutics Inc (AKRO)?
        Vanguard owns the most shares of Akero Therapeutics Inc (AKRO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis